Sanofi quarterly profit exceeded forecasts

110212

The net profit of Sanofi, the pharmaceutical concern from France, grew in the third quarter by 10.3% and amounted to 2 billion 300 million euros. The indicator exceeded the experts' forecasts of 2 billion 140 million euros. Revenues for the quarter of 9 billion 400 million euros were also higher than market estimates of 9 billion 300 million euros. Its growth was 6.3%. Sales of the Genzyme division, which produces vaccines and drugs for the treatment of rare diseases, increased by 36.1%. Growth in revenue from the sale of vaccines was 8.2%. Good quarterly results allowed the company to raise the forecast for the current year for the second time in a year. Now, it expects earnings per share for the year to grow by 4-5%.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong
Message: